流甲丙脯氨酸（captopril，CPT）又称卡托普利，是第一代血管紧张素转化酶（ACE）抑制剂．自1981年试用于临床至今已达15年。从当初仅用于高血压病的治疗，已逐步扩大到充血性心力衰竭、缺血性心肌病、甲状腺机能亢进症、类风湿性关节炎、肾病综合征、原发性醛固酮增多症等多种 Captopril (captopril, also known as captopril, is the first generation of angiotensin-converting enzyme (ACE) inhibitors. Since 1981, clinical trials have so far reached 15 years. From the original only for the treatment of hypertension, has gradually expanded to congestive heart failure, ischemic cardiomyopathy, hyperthyroidism, rheumatoid arthritis, nephrotic syndrome, primary aldosteronism and many other